跳至主要内容
临床试验/ACTRN12623000211662
ACTRN12623000211662已完成2 期

A Biomarker-Driven Approach to Identify Pathogenic Mechanisms and Novel Therapeutic Targets in Chronic Wounds (Pyoderma Gangrenosum) using Tildrakizumab

iverpool Hospital0 个研究点目标入组 10 人开始时间: 2023年2月28日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 99 Years(—)
性别
All

入选标准

  • Age greater than or equal to 18 years
  • A minimum of one (1) active ulcer of Pyoderma Gangrenosum as determined by the PI

排除标准

  • Women lactating, pregnant or of childbearing potential who are not willing to avoid becoming pregnant during the study.
  • Individuals with concurrent use of systemic antibiotics/ oral retinoids/ systemic immunosuppressants (those with prior use of these medications must have conducted a washout period of 4 weeks or 5 half-lives of the drug, whichever is longer).
  • Any medical, psychological or social condition that, in the opinion of the Investigator, would jeopardize the health or well-being of the participant during any study procedures or the integrity of the data.
  • Have received a vaccination with a live viral of bacterial component within 4 weeks or less of intended Tildrakizumab administration
  • Patients not willing to abstain from receiving live vaccinations during treatment and for at least 17 weeks after treatment

研究者

发起方
iverpool Hospital

相似试验

招募中
不适用
Identification and analysis of biomarkers for the course of demyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosisDemyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosis
DRKS00031139MPI-NAT1,000
招募中
不适用
Discovery of Novel Biomarkers for the Diagnosis of TB DiseaseA15Respiratory tuberculosis, bacteriologically and histologically confirmed
DRKS00032445Roche360
招募中
不适用
Testing novel biomarkers for the diagnosis of the delayed sleep wake phase disorder (DSWPD) in young adultsG47Sleep disorders
DRKS00030981Charitè Universitätmedizin (Chronobiology Lab)32
尚未招募
不适用
Identification of biomarkers and pathogenesis of lung cancer without targeted metabolomics based on uplc-q-tof /MSung cancer
ITMCTR1900002555The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
招募中
不适用
Clinical, molecular and functional biomarkers for PROgnosis, pathomechanisms and treatment strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)Coronavirus Disease 19 (COVID-19)U07.1J12J13J14J15J16J17J18COVID-19, virus identifiedViral pneumonia, not elsewhere classifiedPneumonia due to Streptococcus pneumoniaePneumonia due to Haemophilus influenzaeBacterial pneumonia, not elsewhere classifiedPneumonia due to other infectious organisms, not elsewhere classifiedPneumonia in diseases classified elsewherePneumonia, organism unspecified
DRKS00022871CAPNETZ STIFTUNG, Geschäftsstelle an der Medizinischen Hochschule Hannover400